27 Jan 2021
2020 Bionow Digital Awards – Shortlisted Nominees Announced
The Bionow Digital Awards for 2020 have announced the shortlist of nominees, showcasing some of the very best of the life sciences sector at an online ceremony on Thursday 4 February 2021.
The evening will bring the sector together, celebrate excellence and provide an opportunity for many across the system to join with friends and colleagues, whilst learning more about some groundbreaking innovations and projects.
Getting together for this special event will recognise the outstanding success and achievements of those who have worked tirelessly this year and spotlight the incredible progress that has been made during this challenging period. What better way to kick start 2021 than to take our hats off to those dedicated companies and individuals.
Geoff Davison, CEO of Bionow said: “Each year we are amazed at the high quality of applications that we receive for the Bionow Awards. With the disruption and challenges that we have all experienced this year, the level of innovation and outstanding results that have been delivered is truly astounding. How the sector has come together and worked tirelessly is remarkable and shows that we really are world-class! We very much look forward to celebrating and honouring these achievements at the Bionow Digital Awards Ceremony on 4th February”.
The evening will start at 5.15pm with virtual networking followed by the Award Ceremony at 6pm.
The 2020 shortlisted nominees are:
- AINOSTICS
- Cellsway
- LUNAC Therapeutics
- QV Bioelectronics
- Manchester University NHS Foundation Trust
Project: Bubble-PAPR: Powered Air-Purifying Respirator hood – protection for everyone - Sky Medical Technology
Project: GekoTM device: Preventing blood clots in obstetrics patients - SpheriTech
Project: Repurposing of a novel wound dressing into an antiviral face mask filter and alcohol-free hand sanitiser
- Centre for Process Innovation
Project: MicroSUN: Microfluidics Scale-up of Nanoformulations - Medicines Discovery Catapult and University of Leeds
Project: Therapeutic Microbubbles safely administer toxic cancer drugs - Phoenix DX
Project: An automated point-of-care device for rapid diagnosis of respiratory infection - S. M. Discovery Group
Project: Nanoligand-Carriers: A versatile drug delivery platform technology for Alzheimer’s disease
- Cievert
Product: Mavis: Mass Vaccination System - Safe Steps
Product: Safe Steps Falls Prevention - Yourgene Health
Product: Elucigene® DPYD assay
- Perfectus Biomed Group
Technical Service: Efficacy testing of products designed to prevent transmission of COVID-19 - Quay Pharma
Technical Service: Pharmaceutical Development and GMP manufacture of Live Bio
Therapeutics - Veratrak
Technical Service: Securing Document Collaboration & Remote Inspections/Audits
- Biofortuna
Project: Large-scale manufacture of lyophilised Covid-19 tests - Cobra Biologics
Project: Tech transfer and manufacturing drug substance scale-up of the Oxford COVID-19 Vaccine - Manchester University NHS Foundation Trust
Project: Bubble-PAPR: Powered Air-Purifying Respirator hood – protection for everyone - Lighthouse Laboratory, Medicines Discovery Catapult
Project: The MDC Alderley Park Lighthouse Laboratory
- Jake Dickinson, Scientist: Data Modelling, Seda Pharmaceutical Development Services
- Jason Lacombe, Chief Executive Officer, Veratrak
- Taelor Patterson, Senior Scientist, Allergan Biologics (an Abbvie Company)
- Arcinova
Product/Service Exported: Development and Manufacture of Drug Substance and Drug products - CatSci
Product/Service Exported: Process research and development services for the pharmaceutical industry - Elixir Software
Product/Service Exported: iTraX – cloud-based software allowing biopharmaceutical companies to simplify the way that scientists collaboratively plan, track and deliver their projects
- Antibiotic Research UK
Project: Adding the Patient Voice to AMR – through support and advocacy - Oppilotech
Project: Developing Novel Antibiotics from Drug Targets Identified Using AI/ML Platform - Pedanius Therapeutics
Project: Bacterial Cell Targeted RNA Therapeutics to Overcome Antimicrobial Resistance
- F2G
Deal: Late stage funding leading to commercialisation of a novel systemic antifungal - Kinomica
Deal: Kinomica-Longwall/BGF Series A Fundraise - Yourgene Health
Deal: Acquisition of Coastal Genomics, Inc. by Yourgene Health plc
To be announced on the evening
- Cobra Biologics
- Fujifilm Diosynth Biotechnologies
- Sygnature Discovery
13 Jan 2021
